Efficacy and Safety of Opicapone in Clinical Practice

计划入组 518 人 · 首次发布于 2016 年 7 月 28 日

Early ParkinSon wIth L-DOPA/DDCI and OpicapoNe (EPSILON Study)

计划入组 410 人 · 首次发布于 2021 年 7 月 27 日

Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients.

计划入组 427 人 · 首次发布于 2010 年 10 月 25 日

Opicapone(Ongentys, Ontilyv)

C₁₅H₁₀Cl₂N₄O₆

Carbidopa(Dhivy, Duodopa, Duopa, Lodosyn, Parcopa, Rytary, Sinemet, Stalevo, Levodopa/Carbidopa/Entacapone Orion)

C₁₀H₁₄N₂O₄ · Rx

oxalate decarboxylase

Dova Pharmaceuticals, Inc.

United States

Doma Biopharmaceutical (Suzhou) Co., Ltd.

China

DONA ANA MEDICAL SUPPLY, LLC

United States

FDA Approves PTC Therapeutics' KEBILIDI, First Gene Therapy Delivered Directly to the Brain for AADC Deficiency

FDA Approves Kebilidi, First Brain-Delivered Gene Therapy for AADC Deficiency

FDA Approves PTC Therapeutics' Gene Therapy KEBILIDI for AADC Deficiency